Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria Potter

Showing results (21-30 of 75) with videos related to

Pageof 8
Sort By:
Leukemia Research|May 3, 2014
Long term follow-up of BEAM-autologous and BEAM-alemtuzumab allogeneic stem cell transplantation in relapsed advanced stage follicular lymphomaVictor Noriega, Harpreet Kaur, Stephen Devereux, et al.
Ejhaem|February 2, 2026
A Pilot Project to Evaluate the Benefit of Additional Support in Haematopoietic Cell Transplant (HCT) Research Data Management on Behalf of Anthony Nolan and BSBMTCTShelley Hewerdine, Greg Judge, Julia Lee, et al.
Mediterranean Journal of Hematology and Infectious Diseases|July 12, 2023
Fludarabine-Melphalan-Campath, Followed by Unmanipulated Peripheral-Blood Haematopoietic Stem Cells, Can Still Cure LymphomaDaniele Avenoso, Amal Alabdulwahab, Michelle Kenyon, et al.
Blood|April 27, 2011
Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemiaJudith C Marsh, Vikas Gupta, Ziyi Lim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 22, 2014
Peripheral blood hematopoietic stem cells for transplantation of hematological diseases from related, haploidentical donors after reduced-intensity conditioningKavita Raj, Antonio Pagliuca, Kenneth Bradstock, et al.
British Journal of Haematology|January 22, 2024
Guidelines for the diagnosis and management of adult aplastic anaemia: A British Society for Haematology GuidelineAustin Kulasekararaj, Jamie Cavenagh, Inderjeet Dokal, et al.
British Journal of Haematology|March 11, 2026
Haematopoietic stem cell transplantation outcomes for teenage and young adult patients with acute leukaemia: A British Society of Blood and Marrow Transplantation and Cellular Therapy registry studyGraham McIlroy, Ben Carpenter, Rachael Hough, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 7, 2016
Mixed T Cell Chimerism After Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia Using an Alemtuzumab-Containing Regimen Is Shaped by Persistence of Recipient CD8 T CellsFrancesco Grimaldi, Victoria Potter, Pilar Perez-Abellan, et al.
Bone Marrow Transplantation|May 30, 2023
Long-term outcome of second allogeneic hematopoietic stem cell transplantation (HSCT2) for primary graft failure in patients with acute leukemia in remission: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationArnon Nagler, Myriam Labopin, Ryszard Swoboda, et al.
Bone Marrow Transplantation|October 25, 2019
Fludarabine/busulfan versus fludarabine/total-body-irradiation (2 Gy) as conditioning prior to allogeneic stem cell transplantation in patients (≥60 years) with acute myelogenous leukemia: a study of the acute leukemia working party of the EBMTThomas Heinicke, Myriam Labopin, Emmanuelle Polge, et al.
Pageof 8

Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
Leukemia Research|May 3, 2014
Long term follow-up of BEAM-autologous and BEAM-alemtuzumab allogeneic stem cell transplantation in relapsed advanced stage follicular lymphomaVictor Noriega, Harpreet Kaur, Stephen Devereux, et al.
Ejhaem|February 2, 2026
A Pilot Project to Evaluate the Benefit of Additional Support in Haematopoietic Cell Transplant (HCT) Research Data Management on Behalf of Anthony Nolan and BSBMTCTShelley Hewerdine, Greg Judge, Julia Lee, et al.
Mediterranean Journal of Hematology and Infectious Diseases|July 12, 2023
Fludarabine-Melphalan-Campath, Followed by Unmanipulated Peripheral-Blood Haematopoietic Stem Cells, Can Still Cure LymphomaDaniele Avenoso, Amal Alabdulwahab, Michelle Kenyon, et al.
Blood|April 27, 2011
Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemiaJudith C Marsh, Vikas Gupta, Ziyi Lim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 22, 2014
Peripheral blood hematopoietic stem cells for transplantation of hematological diseases from related, haploidentical donors after reduced-intensity conditioningKavita Raj, Antonio Pagliuca, Kenneth Bradstock, et al.
British Journal of Haematology|January 22, 2024
Guidelines for the diagnosis and management of adult aplastic anaemia: A British Society for Haematology GuidelineAustin Kulasekararaj, Jamie Cavenagh, Inderjeet Dokal, et al.
British Journal of Haematology|March 11, 2026
Haematopoietic stem cell transplantation outcomes for teenage and young adult patients with acute leukaemia: A British Society of Blood and Marrow Transplantation and Cellular Therapy registry studyGraham McIlroy, Ben Carpenter, Rachael Hough, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 7, 2016
Mixed T Cell Chimerism After Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia Using an Alemtuzumab-Containing Regimen Is Shaped by Persistence of Recipient CD8 T CellsFrancesco Grimaldi, Victoria Potter, Pilar Perez-Abellan, et al.
Bone Marrow Transplantation|May 30, 2023
Long-term outcome of second allogeneic hematopoietic stem cell transplantation (HSCT2) for primary graft failure in patients with acute leukemia in remission: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationArnon Nagler, Myriam Labopin, Ryszard Swoboda, et al.
Bone Marrow Transplantation|October 25, 2019
Fludarabine/busulfan versus fludarabine/total-body-irradiation (2 Gy) as conditioning prior to allogeneic stem cell transplantation in patients (≥60 years) with acute myelogenous leukemia: a study of the acute leukemia working party of the EBMTThomas Heinicke, Myriam Labopin, Emmanuelle Polge, et al.
Pageof 8